Abstract

Tumor heterogeneity can be traced back to a small subset of cancer stem cells (CSCs), which can be derived from a single stem cell and show chemoresistance. Recent studies showed that CSCs are sensitive to mitochondrial targeting antibiotics such as doxycycline. However, little is known about how cancer cells undergo sphere formation and how antibiotics inhibit CSC proliferation. Here we show that under sphere-forming assay conditions, prostate cancer cells acquired CSC-like properties: promoted mitochondrial respiratory chain activity, expression of characteristic CSC markers and resistance to anticancer agents. Furthermore, those CSC-like properties could reversibly change depending on the culture conditions, suggesting some kinds of CSCs have plasticity in tumor microenvironments. The sphere-forming cells (i.e. cancer stem-like cells) showed increased contact between mitochondria and mitochondrial associated-endoplasmic reticulum (ER) membranes (MAM). Mitochondrial targeting doxycycline induced activating transcription factor 4 (ATF4) mediated expression of ER stress response and led to p53-upregulated modulator of apoptosis (PUMA)-dependent apoptosis only in the cancer stem-like cells. We also found that doxycycline effectively suppressed the sphere formation in vitro and blocked CD44v9-expressing tumor growth in vivo. In summary, these data provide new molecular findings that monolayer cancer cells acquire CSC-like properties in a reversible manner. These findings provide important insights into CSC biology and a potential new treatment of targeting mitochondria dependency.

Highlights

  • The subpopulation of tumor cells commonly known as tumor-initiating cells, or cancer stem cells (CSCs), plays a critical role in tumorigenesis and is present in various types of cancer[1]

  • We previously reported that oncogenic HRas indirectly suppressed the mitochondrial oxygen consumption rate (OCR), oxygen consumption is essential for tumorigenesis[24]

  • We first investigated the characteristics of CSCs which derived from sphere-forming assays in various cell lines

Read more

Summary

Introduction

The subpopulation of tumor cells commonly known as tumor-initiating cells, or cancer stem cells (CSCs), plays a critical role in tumorigenesis and is present in various types of cancer[1]. The sphere-forming assay is commonly used to culture stem-like cancer cell lines on a low adhesion plate in a serum-free medium[8, 9]. In these conditions, approximately one percent of prostate cancer (DU145) monolayer cells are able to form sphere-forming colonies and this small population was thought to be CSCs in this assay. Little is known as to how sphere-forming cells are selected or generated under those conditions from cultured monolayer cell and why these sphere-forming cells can represent CSCs. The stemness is maintained in special environments called microenvironments or niche[10, 11]. We called the CD44v9 positive cells with the CSC properties as cancer stem-like cells (CSC-like) because we did not examine a stemness of these cells

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call